The deubiquitinating enzyme USP1 regulates the fanconi anemia pathway

Molecular Cell

Volumn 17, Issue 3, 2005, Pages 331-339

  Nijman, Sebastian M B ^a   Huang, Tony T ^b   Dirac, Annette M G ^a   Brummelkamp, Thijn R ^a   Kerkhoven, Ron M ^a   D'Andrea, Alan D ^b   Bernards, René ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ENZYME; FANCONI COMPLEMENTATION GROUP D2 PROTEIN; PROTEIN; PROTEIN USP1; RNA; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN; CHROMOSOME ABERRATION; CONTROLLED STUDY; CROSS LINKING; DNA DAMAGE; DNA REPAIR; EMBRYO; ENZYME ANALYSIS; ENZYME INHIBITION; FANCONI ANEMIA; GENE LIBRARY; GENETIC SCREENING; HUMAN; HUMAN CELL; MULTIGENE FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; UBIQUITINATION;

ANIMALS; BASE SEQUENCE; CELL CYCLE; CELL LINE; CHROMATIN; CHROMOSOME ABERRATIONS; DNA REPAIR; ENDOPEPTIDASES; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; GENE LIBRARY; HUMANS; MICE; MITOMYCIN; MUTATION; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITIN;

EID: 13244291457     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2005.01.008     Document Type: Article

References (39)

1. Agami R., Bernards R. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell. 102:2000;55-66
2. Andreassen P.R., D'Andrea A.D., Taniguchi T. ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev. 18:2004;1958-1963
3. Auerbach A.D., Rogatko A., Schroeder-Kurth T.M. International Fanconi Anemia Registry. relation of clinical symptoms to diepoxybutane sensitivity Blood. 73:1989;391-396
4. Brummelkamp T.R., Bernards R., Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell. 2:2002;243-247. a
5. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553. b
6. Brummelkamp T.R., Nijman S.M., Dirac A.M., Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature. 424:2003;797-801
7. Chung C.H., Baek S.H. Deubiquitinating enzymes. their diversity and emerging roles Biochem. Biophys. Res. Commun. 266:1999;633-640
8. Cummins J.M., Rago C., Kohli M., Kinzler K.W., Lengauer C., Vogelstein B. Tumour suppression. disruption of HAUSP gene stabilizes p53 Nature. 428:2004;486
9. D'Andrea A., Pellman D. Deubiquitinating enzymes. a new class of biological regulators Crit. Rev. Biochem. Mol. Biol. 33:1998;337-352
10. D'Andrea A.D. The Fanconi road to cancer. Genes Dev. 17:2003;1933-1936
11. de Winter J.P., van der Weel L., de Groot J., Stone S., Waisfisz Q., Arwert F., Scheper R.J., Kruyt F.A., Hoatlin M.E., Joenje H. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9:2000;2665-2674
12. Fujiwara T., Saito A., Suzuki M., Shinomiya H., Suzuki T., Takahashi E., Tanigami A., Ichiyama A., Chung C.H., Nakamura Y., Tanaka K. Identification and chromosomal assignment of USP1, a novel gene encoding a human ubiquitin-specific protease. Genomics. 54:1998;155-158
13. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell. 7:2001;249-262
14. Gordon S.M., Buchwald M. Fanconi anemia protein complex. mapping protein interactions in the yeast 2- and 3-hybrid systems Blood. 102:2003;136-141
15. Graner E., Tang D., Rossi S., Baron A., Migita T., Weinstein L.J., Lechpammer M., Huesken D., Zimmermann J., Signoretti S., Loda M. The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell. 5:2004;253-261
16. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 297:2002;606-609
17. Kim J.H., Park K.C., Chung S.S., Bang O., Chung C.H. Deubiquitinating enzymes as cellular regulators. J. Biochem. (Tokyo). 134:2003;9-18
18. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., Courtois G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature. 424:2003;801-805
19. Levitus M., Rooimans M.A., Steltenpool J., Cool N.F., Oostra A.B., Mathew C.G., Hoatlin M.E., Waisfisz Q., Arwert F., de Winter J.P., Joenje H. Heterogeneity in Fanconi anemia. evidence for 2 new genetic subtypes Blood. 103:2004;2498-2503
20. Li M., Chen D., Shiloh A., Luo J., Nikolaev A.Y., Qin J., Gu W. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 416:2002;648-653
21. Mason D.E., Ek J., Peters E.C., Harris J.L. Substrate profiling of deubiquitin hydrolases with a positional scanning library and mass spectrometry. Biochemistry. 43:2004;6535-6544
22. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35:2003;165-170. a
23. Meetei A.R., Levitus M., Xue Y., Medhurst A.L., Zwaan M., Ling C., Rooimans M.A., Bier P., Hoatlin M., Pals G., et al. X-linked inheritance of Fanconi anemia complementation group B. Nat. Genet. 36:2004;1219-1224
24. Meetei A.R., Sechi S., Wallisch M., Yang D., Young M.K., Joenje H., Hoatlin M.E., Wang W. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23:2003;3417-3426. b
25. Nakanishi K., Taniguchi T., Ranganathan V., New H.V., Moreau L.A., Stotsky M., Mathew C.G., Kastan M.B., Weaver D.T., D'Andrea A.D. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat. Cell Biol. 4:2002;913-920
26. Niedzwiedz W., Mosedale G., Johnson M., Ong C.Y., Pace P., Patel K.J. The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol. Cell. 15:2004;607-620
27. Pace P., Johnson M., Tan W.M., Mosedale G., Sng C., Hoatlin M., de Winter J., Joenje H., Gergely F., Patel K.J. Fance. the link between fanconi anaemia complex assembly and activity EMBO J. 21:2002;3414-3423
28. Papa F.R., Hochstrasser M. The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene. Nature. 366:1993;313-319
29. Papadopoulo D., Guillouf C., Mohrenweiser H., Moustacchi E. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. Proc. Natl. Acad. Sci. USA. 87:1990;8383-8387
30. Shackelford J., Pagano J.S. Tumor viruses and cell signaling pathways. deubiquitination versus ubiquitination Mol. Cell. Biol. 24:2004;5089-5093
31. Sonoda E., Okada T., Zhao G.Y., Tateishi S., Araki K., Yamaizumi M., Yagi T., Verkaik N.S., van Gent D.C., Takata M., Takeda S. Multiple roles of Rev3, the catalytic subunit of polzeta in maintaining genome stability in vertebrates. EMBO J. 22:2003;3188-3197
32. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood. 100:2002;2414-2420. a
33. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P.R., Gregory R.C., Kim S.T., Lane W.S., Kastan M.B., D'Andrea A.D. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell. 109:2002;459-472. b
34. Taniguchi T., Tischkowitz M., Ameziane N., Hodgson S.V., Mathew C.G., Joenje H., Mok S.C., D'Andrea A.D. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat. Med. 9:2003;568-574
35. Tischkowitz M., Ameziane N., Waisfisz Q., De Winter J.P., Harris R., Taniguchi T., D'Andrea A., Hodgson S.V., Mathew C.G., Joenje H. Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia. Br. J. Haematol. 123:2003;469-471
36. Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H., Ashworth A., Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature. 424:2003;793-796
37. Wang X., Andreassen P.R., D'Andrea A.D. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol. 24:2004;5850-5862
38. Whitfield M.L., Sherlock G., Saldanha A.J., Murray J.I., Ball C.A., Alexander K.E., Matese J.C., Perou C.M., Hurt M.M., Brown P.O., Botstein D. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell. 13:2002;1977-2000
39. Wilkinson K.D. Ubiquitination and deubiquitination. targeting of proteins for degradation by the proteasome Semin. Cell Dev. Biol. 11:2000;141-148